Egg Allergy Market Research Report - Global Forecast till 2027

Global Egg Allergy Market: Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/3312-CR | July 2019 | Region: Global | 133 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


The egg allergy market is emerging rapidly in the global economy and will further rise to extreme heights in the near future. The egg allergy market valuation is estimated to reach around USD 2304.3 million by 2023, with a predicted CAGR or compound annual growth rate of 7.10 percent in the forecast period from 2018 to 2023.


The global egg allergy market is rising at a faster rate due to the surge of egg allergy incidence taking place in recent times. According to the British Society for Allergy & Clinical Immunology data, the ubiquity of food allergies has grown, and 6 to 8 percent of children getting affected by the same. These allergies affect both infants as well as adults and can happen in few minutes or take few hours. Egg allergy symptoms in adults can happen due to egg overreaction by the body's immune system. The body's immune system identifies egg protein as hazardous and triggers an allergic reaction. The extreme ubiquity of egg allergies will expand the egg allergy market size in the forecast years.


With the rising cases of egg allergies, there is a significant increase in the production of egg allergy medication. The improvements in egg allergy treatment and diagnosis have created a conducive environment for the egg allergy market growth. Several treatments and diagnosis methods after technological advancements include blood tests, skin prick tests, food challenge, and many more. Besides all these procedures, oral immunotherapy is also a stream of treating egg allergies which enhances the skin allergy test market size.


The egg allergy in adults varies differently and can show a reaction in the form of hives or rashes or extremely severe anaphylaxis. The continuous growth of skin allergy patients is accountable for the increasing demand for egg allergy medication and egg allergy treatment like epinephrine auto-injectors and others. These developments in treatment and diagnosis are surging the growth of the egg allergy market.


The report describes the insights of the egg allergy market and the factors influencing it. It covers the impact of COVID19 on the egg allergy market size and reflects the market dynamics that show the opportunities and challenges of market growth. A brief description is provided for the market segmentation and the egg allergy market study on different regions that can drive the market growth in the forecast period.


COVID19 Analysis


The coronavirus pandemic outbreak has severely affected the economic growth rate globally. Industrial sectors, as well as working sectors, were shut down due to the lockdown restrictions. The world suffered in the field of both health as well as economy. The manufacturing units of pharmaceuticals remained closed and created big disruptions in the supply chain of the egg allergy market


During the lockdown, the demand for eggs comparatively decreased, and the number of cases of egg allergies significantly reduced. The production of egg allergy medication slowed down, which constrain the skin allergy market size. As the egg allergy market is solely dependent on the number of egg allergy cases, the market growth was hampered. However, the advent of new developments in egg allergy treatment and diagnosis resulted in maintaining a steady growth of the market and will contribute to growing allergy skin test market share in the upcoming years.


Market Dynamics



  • Major drivers of the market


The egg allergy market size is evolving at a faster pace, and in the upcoming times, it will grow immensely. The number of cases of egg allergies is increasing day by day, both in adults as well as infants. Most number of cases over the years has happened to children more than egg allergy in adults. Symptoms of egg allergy in children outgrow way before it results in egg allergy symptoms in adults. The food allergy prevalence has increased to a greater extent which acts as a driving force for the growth of the global egg allergy market. Several technological advancements in egg allergy medication and treatment resulted in propelling the egg allergy market size. 


The technological advancements in egg allergy treatment and diagnosis methods include skin prick test, food challenge, blood test, oral immunotherapy, and many more. These advanced methods of treatment increase the skin allergy test market size and help to propagate the growth of the egg allergy market to the optimum level in the forecast period.



  • Significant growth opportunities for the market


The egg allergy market is increasing to greater heights in a short time span, and the market will continue to grow in the future due to an extreme increase in egg allergy cases. The skin allergy test market size is rising exponentially with the advanced technological methods of diagnosis and treatment. These advancements are not just limited to egg allergy treatment but also include advancements in the identification process and screening. Various food scanners, apps, portable devices, and wearable are helpful in determining different food ingredients related to egg allergy. These devices are major opportunities for increasing the egg allergy market size in the upcoming years.



  • Market restraints


The global egg allergy market is definitely growing at a faster rate, but the market growth can be hindered due to a lack of awareness among patients. The developing countries tend to avoid allergies, and the reason behind it lacks awareness. Many patients overlook the allergies and do not take any egg allergy treatment on time. The egg allergy cases in these countries are comparatively low, and the poor healthcare sector is also responsible for the same. Another prime restraint for the egg allergy market is the hefty cost involved in the diagnosis and treatment process. Many tests are also not covered by any insurance policies. Such constraints restrict the growth of the egg allergy market size.



  • Market Growth Challenges


The egg allergy market is immensely dependent on the number of cases of egg allergy patients. Many patients overlook and avoid egg allergy medication in time which leads to declining market growth. Various tests like radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA or EIA) has their own limitations, which sometimes show false results and diagnosis failure due to cross-contamination. These testing procedures also require proficient egg allergy market therapeutics who can handle the tests properly, which hinders the market growth of the global egg allergy market size.


Value Chain Analysis


The revenue of the egg allergy market is continuously escalating over the years and will continue to grow in the forecast years. Various egg research and consultancy sectors are focusing on the prevention and cure of the disease. The continuous effort for producing better egg allergy medication has resulted in the increasing the market value of the egg allergy market. The expansion of skin allergy test market size will reach greater levels in the upcoming years.


Segment Overview


The global egg allergy market is fragmented on the basis of age group, treatment and diagnosis, end-user, and region. The egg allergy market size segmentation on the basis of age group includes children and adults. The egg allergy symptoms in adults are very less compared to children, so the children have the largest share in the egg allergy market. The treatment segment consists of sub-segments that include egg allergy medication and oral immunotherapy process, whereas the diagnosis segment consists of tests like blood tests, skin tests, and others.


Egg allergy market segmentation on the basis of end-user comprises hospitals and clinics, egg research and consultancy, and diagnostics centers. The egg allergy market segmentation on the basis of the region involves various geographies like North America, Europe, South America, Asia Pacific, Middle East, and Africa.


Regional Analysis


The egg allergy market is studied in different geographies such as North America, Europe, South America, Asia Pacific, Middle East, and Africa. The Americas hold the largest allergy skin test market share and are projected to dominate during the forecast period. The government initiatives and support, as well as the majority of companies engaging in the production of products treating egg allergy, will act as a market booster for the Americas.


The European region is expected to acquire the second-largest share in the forecast years due to increasing awareness and safety concerns for children. The Asia Pacific is the rapidly evolving market with the highest rates of implementation of new technologies, which will fuel the market growth in the next many years.


Competitive Landscape of the market


The major players of the egg allergy market are:



  • Genentech, Inc. (the US)

  • Sanofi SA (France),

  • ImmuneTech (US)

  • Quest Diagnostics (US)

  • HYCOR Biomedical (US), 

  • Alletess Medical Laboratory (US)

  • Kaleo, Inc. (the US)

  • Imutest Ltd (UK)

  • Creative Diagnostics (US)

  • Impax Laboratories (US)

  • Mylan NV (US)



Frequently Asked Questions (FAQ) :


Egg allergy market projected to grow at approximately 7.10% CAGR during the assessment period (2020-2027).

The valuation of the global egg allergy market is estimated to increase to USD 2304.3 MN by the end of 2023.

Increasing prevalence, improved allergy diagnosis, and rising healthcare expenses are major tailwinds pushing the growth of the global egg allergy market.

North America holds the largest share in the global egg allergy market, followed by Europe and the Asia Pacific, respectively.

Genetech, Inc. (US), Mylan N.V. (US), Sanofi (France), Alletess Medical Laboratory (US), Creative Diagnostics (US), HYCOR Biomedical (US), Impax Laboratories, Inc. (US), Kaleo, Inc. (US), Kaleo, Inc. (US), Impax Laboratories (US), Quest Diagnostics (US), ImmuneTech (US), and Imutest Ltd. (UK), are some of the top players operating in the global egg allergy market.

The Global Egg Allergy Market is estimated to register a CAGR of 7.10% and is due to reach USD 2304.3 Mn by the end of the forecast period of 2018-2023, reveals Market Research Future (MRFR) in an extensive study. The Global Egg Allergy Marketwas valued at USD 1526.8 Mn in 2017. Recent years has observed a surge in the incidence of egg allergy, especially in children but generally, outgrow before adolescence. As per the data of the British Society for Allergy & Clinical Immunology, the prevalence of food allergies has increased, and 6 to 8% of children are affected with it. Against this backdrop, there has been substantial demand for diagnosis and treatment which propels the growth of the global egg allergy market. There have been notable improvements in allergy diagnosis and treatment procedures which creates a conducive environment for the growth of the global egg allergy market. Various technological advancements have been made in the egg allergy arena which has led to better diagnosis and treatment methods such as skin prick test, blood test, food challenge, and others. Besides, oral immunotherapy has cropped up as a new line of treatment for egg allergy.


 Lack of awareness in developing countries remains an impediment for the growth of the global egg allergy market. Due to lack of awareness, people in developing countries tend to overlook allergies and avoid proper treatment fir the same. The number of registered cases for egg allergies is very low in developing countries, and also poor healthcare infrastructure in such places constrain the growth of the market. Allergy detection generally includes blood tests, skin tests and others which involve hefty costs. According to the American Board of Internal Medicine, a skin test approximately costs around USD 60 to USD 300 whereas, a blood test can cost around USD 200 to USD 1,000. Moreover, such tests are generally not covered under insurance policies. Technological advancements in screening such as food scanners, portable devices, apps, and warbles provide noteworthy opportunities to the global egg allergy market. These devices can be helpful in determining food ingredients which may assist in dealing with egg allergy. To meet the demands of the growing egg allergy patient pool, market players are investing heavily in research and development. For instance, AgraQuant Egg test kit used in laboratories is accurate and reliable enzyme-linked immunosorbent assay (ELISA) that allows testing around 38 samples in around 30 minutes.


Allergy blood tests include Enzyme-linked immunosorbent assay (ELISA or EIA) and Radioallergosorbent test (RAST). However, ELISA testing has its own set of limitations such as false positive results and miss diagnosis due to cross contamination. Also, such advanced tests require skilled professionals to perform the tests which pose a challenge for the growth of the global egg allergy market. The segmentation of the Egg Allergy Market has been carried out on the basis of age group, diagnosis & treatment, and end user. On the basis of age group, the Global Egg Allergy Market been segmented into children (0-18 years and adults (18+ years). the children segment accounts for the larger share of the market. Children are most likely to acquire egg allergy and increase in birth rate, and surging awareness about children safety can be credited for the growth of this segment. On the basis of diagnosis & treatment, the Global Egg Allergy Market has been segmented into treatment and diagnosis. The diagnosis segment is the leading segment and is expected to expand at a CAGR of 7.37% over the forecast period. Increase in demand for efficient diagnostic methods and acceptance of new technologies in the healthcare sector drives the growth of the diagnosis segment.


The diagnosis segment includes sub-segments such as skin test, blood test, food challenge, and others. The skin test sub-segment accounts for the foremost share of the market skin tests provide immediate results in diagnosis of egg allergy and are covered by health insurers which makes them highly preferred over blood tests. The skin test sub-segment is likely to grow at a CAGR of 7.64% over the forecast period. The treatment segment includes sub-segments such as medication and oral immunotherapy. The medication sub-segment accounts for the maximum share of the market while the oral immunotherapy sub-segment is expected to be the fastest growing segment over the forecast period. Oral immunotherapy is a new line of treatment and is increasingly gaining prominence. The medication sub-segment includes antihistamine, epinephrine, and others. Epinephrine is the preferred choice of medication in case of egg allergy since it is self-injectable and is helpful in the prevention of fatal effects of anaphylaxis. On the basis of end user, the Global Egg Allergy Market has been segmented into hospitals & clinics, diagnostic centers, research institutes, and others. The hospitals & clinics segment is the largest segment while the research institutes segment is anticipated to be the fastest growing segment.


Regional Analysis:
Geographically, the Global Egg Allergy Market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa. The Americas hold the foremost share of 40% of the global egg allergy market and is anticipated to expand at a CAGR of 6.46% over the forecast period. The market growth can be attributed to the widespread prevalence of anaphylaxis in the region, especially in children. The Food Allergy Research and Education (FARE) reported around 15 Million people in the US to be suffering from food allergies. In July 2013, legislation made it mandatory for schools to keep stock of epinephrine to combat emergency medical situations. Government initiatives coupled with the presence of prominent market players in the region support the growth of the Americas market.


Europe is the second largest market for egg allergy and was valued at USD 406.4 Million in 2017. The Europe egg allergy market is driven by surging cases of egg allergy, an increase in healthcare expenditure, and investment in R&D in the region. APAC is slated to be the fastest growing market for egg allergy over the forecast period at a CAGR of 8.71%. The untapped markets in the region present a myriad of opportunities for growth where a large patient pool drives the market. In addition, favorable government policies and the adoption of new technologies in countries such as China, Korea, and Japan support market growth in APAC.


Competition Tracking:
The eminent players in the global egg allergy market include Imutest Ltd. (UK), Creative Diagnostics (US), ImmuneTech (US), Mylan N.V. (US), Impax Laboratories (US), Quest Diagnostics (US), Impax Laboratories, Inc (US), Kaleo, Inc. (US), Sanofi (France), Kaleo, Inc. (US), HYCOR Biomedical (US), Genetech, Inc. (US), Alletess Medical Laboratory (US).

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 19

3.2 Scope of the Study 19

3.3 Assumptions & Limitations 19

3.3.1 Assumptions 19

3.3.2 Limitations 19

3.4 Market Structure 20

4 Research Methodology

4.1 Research Process 22

4.2 Primary Research 23

4.3 Secondary Research 24

4.4 Market Size Estimation 25

4.5 Forecast Model 25

5 Market Dynamics

5.1 Introduction 27

5.2 Drivers 28

5.2.1 Increasing Prevalence of Egg Allergy 28

5.2.2 Improved Allergy Diagnosis 28

5.3 Restraints 28

5.3.1 Lack of Awareness in Developing Countries 28

5.3.2 High Cost 28

5.4 Opportunity 29

5.4.1 Technological Advancements in Screening 29

5.5 Challenges 29

5.5.1 Technical Difficulties During Testing 29

6 Market Factor Analysis

6.1 Value Chain Analysis 31

6.2 R&D 31

6.3 Product Development 31

6.4 Manufacturing 31

6.5 Marketing and Distribution 31

6.6 Porter’s Five Forces Analysis 32

6.6.1 Bargaining Power of Suppliers 32

6.6.2 Bargaining Power of Buyers 32

6.6.3 Threat of New Entrants 33

6.6.4 Threat of Substitutes 33

6.6.5 Intensity of Rivalry 33

6.7 Investment Opportunities 33

6.8 Demand & Supply: Gap Analysis 34

6.9 Price Analysis 34

7 Global Egg Allergy Market, By Age group

7.1 Introduction 36

7.1.1 Children (0-18 years) 37

7.1.2 Adults (18 + years) 38

8 Global Egg Allergy Market, By Diagnosis & Treatment

8.1 Introduction 40

8.1.1 Diagnosis 41

8.1.1.1 Skin Test 42

8.1.1.2 Blood Test 42

8.1.1.3 Food Challenge 43

8.1.2 Treatment 43

8.1.2.1 Medication 45

8.1.2.2 Oral immunotherapy 46

9 Global Egg Allergy Market, By End User

9.1 Introduction 48

9.1.1 Hospitals & Clinics 49

9.1.2 Diagnostic Centres 50

9.1.3 Research institute 50

10 Global Egg Allergy Market, By Region

10.1 Introduction 52

10.2 Americas 54

10.2.1 North America 56

10.2.1.1 US. 58

10.2.1.2 Canada 60

10.2.2 South America 62

10.3 Europe 65

10.3.1 Western Europe 67

10.3.1.1 France 69

10.3.1.2 Germany 71

10.3.1.3 Italy 73

10.3.1.4 UK 75

10.3.1.5 Spain 77

10.3.1.6 Rest of Western Europe 79

10.3.2 Eastern Europe 81

10.4 Asia-Pacific 84

10.4.1 Japan 87

10.4.2 China 89

10.4.3 India 91

10.4.4 Australia 93

10.4.5 South Korea 95

10.4.6 Rest of Asia-Pacific 97

10.5 The Middle East and Africa 99

10.5.1 Middle east 101

10.5.2 Africa 103

11 Competitive Landscape

11.1 Company Market Share Analysis 107

11.1.1 Introduction 107

12 Company Profiles

12.1 Sanofi SA 109

12.1.1 Company Overview 109

12.1.2 Financial Overview 109

12.1.3 Products Offering 110

12.1.4 Key Developments 110

12.1.5 SWOT Analysis 110

12.1.6 Key Strategy 110

12.2 Genentech, Inc. 111

12.2.1 Company Overview 111

12.2.2 Financial Overview 111

12.2.3 Products Offering 112

12.2.4 Key Developments 112

12.2.5 SWOT Analysis 112

12.2.6 Key Strategy 112

12.3 Quest Diagnostics 113

12.3.1 Company Overview 113

12.3.2 Financial Overview 113

12.3.3 Products Offering 114

12.3.4 Key Development 114

12.3.5 SWOT Analysis 114

12.3.6 Key Strategy 114

12.4 ImmuneTech 115

12.4.1 Company Overview 115

12.4.2 Financial Overview 115

12.4.3 Products Offering 115

12.4.4 Key Development 115

12.4.5 SWOT Analysis 115

12.4.6 Key Strategy 115

12.5 HYCOR Biomedical 116

12.5.1 Company Overview 116

12.5.2 Financial Overview 116

12.5.3 Products Offering 116

12.5.4 Key Development 116

12.5.5 SWOT Analysis 116

12.5.6 Key Strategy 116

12.6 Kaleo, Inc. 117

12.6.1 Company Overview 117

12.6.2 Financial Overview 117

12.6.3 Products Offering 117

12.6.4 Key Developments 117

12.6.5 SWOT Analysis 117

12.6.6 Key Strategy 117

12.7 Alletess Medical Laboratory 118

12.7.1 Company Overview 118

12.7.2 Financial Overview 118

12.7.3 Products Offering 118

12.7.4 Key Developments 118

12.7.5 SWOT Analysis 118

12.7.6 Key Strategy 119

12.8 Creative Diagnostics 120

12.8.1 Company Overview 120

12.8.2 Financial Overview 120

12.8.3 Products Offering 120

12.8.4 Key Developments 120

12.8.5 SWOT Analysis 121

12.8.6 Key Strategy 121

12.9 Imutest Ltd 122

12.9.1 Company Overview 122

12.9.2 Financial Overview 122

12.9.3 Products Offering 122

12.9.4 Key Developments 122

12.9.5 SWOT Analysis 122

12.9.6 Key Strategy 122

12.10 Mylan NV 123

12.10.1 Company Overview 123

12.10.2 Financial Overview 123

12.10.3 Products Offering 124

12.10.4 Key Developments 124

12.10.5 SWOT Analysis 124

12.10.6 Key Strategy 124

12.11 Impax Laboratories 125

12.11.1 Company Overview 125

12.11.2 Financial Overview 125

12.11.3 Products Offering 125

12.11.4 Key Developments 126

12.11.5 SWOT Analysis 126

12.11.6 Key Strategy 126

13 Appendix

13.1 Discussion Blue Print 128

14 List of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 PRIMARY INTERVIEWS 22

TABLE 3 GLOBAL EGG ALLERGY MARKET BY AGE GROUP, 2020–2027 (USD MILLION) 37

TABLE 4 GLOBAL EGG ALLERGY MARKET FOR CHILDREN, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL EGG ALLERGY MARKET FOR ADULTS, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL EGG ALLERGY MARKET BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 40

TABLE 7 GLOBAL EGG ALLERGY MARKET FOR DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 8 GLOBAL EGG ALLERGY MARKET FOR DIAGNOSIS BY TYPE, 2020–2027 (USD MILLION) 41

TABLE 9 GLOBAL EGG ALLERGY MARKET FOR SKIN TEST, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 10 GLOBAL EGG ALLERGY MARKET FOR BLOOD TEST, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 11 GLOBAL EGG ALLERGY MARKET FOR FOOD CHALANGE, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 12 GLOBAL EGG ALLERGY MARKET FOR TREATMENT, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL EGG ALLERGY MARKET FOR TREATMENT BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 14 GLOBAL EGG ALLERGY MARKET FOR MEDICATION BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 15 GLOBAL EGG ALLERGY MARKET FOR MEDICATION, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 16 GLOBAL EGG ALLERGY MARKET FOR ORAL IMMUNOTHERAPY, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 17 GLOBAL EGG ALLERGY MARKET FOR END USER BY REGION, 2020–2027 (USD MILLION) 49

TABLE 18 GLOBAL EGG ALLERGY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 19 GLOBAL EGG ALLERGY MARKET FOR DIAGNOSTIC CENTRES, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 20 GLOBAL EGG ALLERGY MARKET FOR RESEARCH INSTITUTE, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 21 GLOBAL EGG ALLERGY MARKET, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 22 AMERICAS: EGG ALLERGY MARKET, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 23 AMERICAS: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 54

TABLE 24 AMERICAS: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 55

TABLE 25 AMERICAS: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 26 AMERICAS: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 27 AMERICAS: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 28 AMERICAS: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 56

TABLE 29 NORTH AMERICAS: EGG ALLERGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 56

TABLE 30 NORTH AMERICAS: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 56

TABLE 31 NORTH AMERICAS: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 56

TABLE 32 NORTH AMERICAS: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 33 NORTH AMERICAS: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 34 NORTH AMERICAS: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 35 NORTH AMERICAS: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 58

TABLE 36 US: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 58

TABLE 37 US: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 58

TABLE 38 US: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 39 US: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 40 US: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 41 US: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 42 CANADA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 60

TABLE 43 CANADA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 60

TABLE 44 CANADA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 45 CANADA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 46 CANADA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 47 CANADA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 48 SOUTH AMERICA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 62

TABLE 49 SOUTH AMERICA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 62

TABLE 50 SOUTH AMERICA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 51 SOUTH AMERICA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 52 SOUTH AMERICA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 53 SOUTH AMERICA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 54 EUROPE: EGG ALLERGY MARKET, BY REGION, 2020–2027 (USD MILLION) 65

TABLE 55 EUROPE: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 65

TABLE 56 EUROPE: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 66

TABLE 57 EUROPE: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 58 EUROPE: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 59 EUROPE: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 60 EUROPE: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 67

TABLE 61 WESTERN EUROPE: EGG ALLERGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67

TABLE 62 WESTERN EUROPE: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 67

TABLE 63 WESTERN EUROPE: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 68

TABLE 64 WESTERN EUROPE: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 65 WESTERN EUROPE: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 66 WESTERN EUROPE: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 67 WESTERN EUROPE: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 68 FRANCE: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 69

TABLE 69 FRANCE: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 69

TABLE 70 FRANCE: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 71 FRANCE: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 72 FRANCE: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 73 FRANCE: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 74 GERMANY: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 71

TABLE 75 GERMANY: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 71

TABLE 76 GERMANY: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 77 GERMANY: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 78 GERMANY: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 79 GERMANY: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 80 ITALY: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 73

TABLE 81 ITALY: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 73

TABLE 82 ITALY: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 83 ITALY: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 84 ITALY: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 85 ITALY: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 75

TABLE 86 UK: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 75

TABLE 87 UK: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 75

TABLE 88 UK: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 89 UK: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 90 UK: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 91 UK: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 77

TABLE 92 SPAIN: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 77

TABLE 93 SPAIN: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 77

TABLE 94 SPAIN: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 95 SPAIN: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 96 SPAIN: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 97 SPAIN: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 98 REST OF WESTERN EUROPE: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 79

TABLE 99 REST OF WESTERN EUROPE: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 79

TABLE 100 REST OF WESTERN EUROPE: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 101 REST OF WESTERN EUROPE: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 102 REST OF WESTERN EUROPE: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 103 REST OF WESTERN EUROPE: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 104 EASTERN EUROPE: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 81

TABLE 105 EASTERN EUROPE: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 81

TABLE 106 EASTERN EUROPE: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 107 EASTERN EUROPE: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 108 EASTERN EUROPE: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 109 EASTERN EUROPE: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 83

TABLE 110 ASIA-PACIFIC: EGG ALLERGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84

TABLE 111 ASIA-PACIFIC: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 85

TABLE 112 ASIA-PACIFIC: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 85

TABLE 113 ASIA-PACIFIC: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 114 ASIA-PACIFIC: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 115 ASIA-PACIFIC: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 116 ASIA-PACIFIC: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 86

TABLE 117 JAPAN: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 87

TABLE 118 JAPAN: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 87

TABLE 119 JAPAN: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 120 JAPAN: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 121 JAPAN: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 122 JAPAN: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 88

TABLE 123 CHINA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 89

TABLE 124 CHINA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 89

TABLE 125 CHINA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 126 CHINA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 127 CHINA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 128 CHINA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 90

TABLE 129 INDIA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 91

TABLE 130 INDIA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 91

TABLE 131 INDIA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 132 INDIA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 133 INDIA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 134 INDIA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 92

TABLE 135 AUSTRALIA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 93

TABLE 136 AUSTRALIA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 93

TABLE 137 AUSTRALIA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 138 AUSTRALIA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 139 AUSTRALIA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 140 AUSTRALIA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 94

TABLE 141 SOUTH KOREA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 95

TABLE 142 SOUTH KOREA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 95

TABLE 143 SOUTH KOREA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 144 SOUTH KOREA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 145 SOUTH KOREA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 146 SOUTH KOREA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 96

TABLE 147 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 97

TABLE 148 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 97

TABLE 149 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 150 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 151 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 152 REST OF ASIA-PACIFIC: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 153 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET, BY REGION, 2020–2027 (USD MILLION) 99

TABLE 154 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 99

TABLE 155 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 100

TABLE 156 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 157 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 158 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 159 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 160 THE MIDDLE EAST: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 101

TABLE 161 THE MIDDLE EAST: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 101

TABLE 162 THE MIDDLE EAST: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 163 THE MIDDLE EAST: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 164 THE MIDDLE EAST: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 165 THE MIDDLE EAST: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 166 AFRICA: EGG ALLERGY MARKET, BY AGE GROUP, 2020–2027 (USD MILLION) 103

TABLE 167 AFRICA: EGG ALLERGY MARKET, BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 103

TABLE 168 AFRICA: EGG ALLERGY MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 169 AFRICA: EGG ALLERGY MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 170 AFRICA: EGG ALLERGY MARKET FOR MEDICATION, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 171 AFRICA: EGG ALLERGY MARKET, BY END USER, 2020–2027 (USD MILLION) 105

15 List of Figures

FIGURE 1 GLOBAL EGG ALLERGY MARKET: MARKET STRUCTURE 20

FIGURE 2 RESEARCH PROCESS 22

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 25

FIGURE 4 MARKET DYNAMICS ANALYSIS OF GLOBAL EGG ALLERGY MARKET 27

FIGURE 5 VALUE CHAIN: GLOBAL EGG ALLERGY MARKET 31

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL EGG ALLERGY MARKET 32

FIGURE 7 GLOBAL EGG ALLERGY MARKET, BY AGE GROUP, 2020 (% SHARE) 36

FIGURE 8 GLOBAL EGG ALLERGY MARKET, BY AGE GROUP, 2020 & 2027 36

FIGURE 9 GLOBAL EGG ALLERGY MARKET, BY DIAGNOSIS & TREATMENT, 2020 (% SHARE) 40

FIGURE 10 GLOBAL EGG ALLERGY MARKET, BY DIAGNOSIS & TREATMENT, 2020 & 2027 40

FIGURE 11 GLOBAL EGG ALLERGY MARKET, BY END USER, 2020 (% SHARE) 48

FIGURE 12 GLOBAL EGG ALLERGY MARKET, BY END USER, 2020 & 2027 48

FIGURE 13 GLOBAL EGG ALLERGY MARKET, BY REGION, 2020 & 2027 (USD MILLION) 52

FIGURE 14 GLOBAL EGG ALLERGY MARKET, BY REGION, 2020 (% SHARE) 52

FIGURE 15 AMERICAS: EGG ALLERGY MARKET SHARE, BY REGION, 2020 (% SHARE) 54

FIGURE 16 EUROPE: EGG ALLERGY MARKET SHARE, BY REGION, 2020 (% SHARE) 65

FIGURE 17 ASIA-PACIFIC: EGG ALLERGY MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 84

FIGURE 18 THE MIDDLE EAST AND AFRICA: EGG ALLERGY MARKET SHARE, REGION, 2020 (% SHARE) 99

FIGURE 19 GLOBAL EGG ALLERGY MARKET, MARKET SHARE ANALYSIS 2020 (% SHARE) 107

Company Analysis:


The Global Egg Allergy Market is currently dominated by many market players such as Mylan N.V. (US), Impax Laboratories, Inc (US), Quest Diagnostics, Sanofi (France), and Kaleo, Inc. (US). In the Global Egg Allergy Market, major companies are opting for new product launches, strategic partnerships, and collaborations to strengthen their market position.


Mylan N.V. holds the largest 12.9% share of the global egg allergy market. The company has a strong portfolio of more than 1000 products. The company’s major strength is its vertically integrated supply chain, strong sales, and distribution network as well as it provides after sales services and support, which play a major role in customers’ satisfaction. The company’s major share is due to its blockbuster product EpiPen, an epinephrine autoinjector used for allergy treatment. Moreover, the company launched the first generic version of its branded product EpiPen in August 2016. This strategy of the company aims to increase the revenue generation in the coming years and to overcome the decreasing sales of the branded EpiPen product owing to pricing issues. Furthermore, the company is engaged in strategic collaborations and mergers which helps the company to hold its market position. For instance, in August 2016, Mylan N.V. acquired Meda AB for USD 7.2 billion.


Quest Diagnostics acquired the second largest spot in the egg allergy market with a market share of 5.6%. The company has a strategy of focusing rare disease diagnosis, maintaining the quality of products by maximum automation, and rising investment on research and development which helps the company in maintaining its market position. Additionally, the company is engaged in strategic acquisitions and collaborations which facilitates the company to strengthen its position and expand its market presence globally.


Impax Laboratories held the third largest position in terms of market share of 2.7%. Impax is one of the major players in the market. Impax has successfully integrated complimentary companies by mergers and acquisitions to build a strong supply chain network. High customer satisfaction level, strong brand portfolio, and exceptional performance in new markets are providing an advantage to Impax Laboratories.


Kaleo, Inc. is a prominent player in the market owing to its unique product AUVI-Q. Kaleo, Inc. acquired the strong position in the egg allergy market with a market share of 2.0%. It is used to treat anaphylaxis attack. Kaleo, Inc. is one of the leading epinephrine providers in the US. The company has a strong research and development department and it focuses on rare diseases and allergies as the company gets maximum revenue from this segment. 


Other prominent companies in the market include Genentech, Inc., Sanofi, ImmuneTech, HYCOR Biomedical, Alletess Medical Laboratory, Creative Diagnostics, Imutest Limited, and Neogen Corporation.